<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04649346</url>
  </required_header>
  <id_info>
    <org_study_id>201907019RINC</org_study_id>
    <nct_id>NCT04649346</nct_id>
  </id_info>
  <brief_title>The Difference of Oropharyngeal Leak Pressure and Sealing Pressure Between New Supraglottic Airway Devices</brief_title>
  <acronym>SGA</acronym>
  <official_title>The Difference of Oropharyngeal Leak Pressure and Sealing Pressure Between New Supraglottic Airway Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The difference of oropharyngeal leak pressure and sealing pressure between new supraglottic&#xD;
      airway devices.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this clinical study, investigators want to discuss the issue that oropharyngeal leak&#xD;
      pressure and sealing condition with different SGA including air-Q、i-gel、LMA-supreme、AMBU&#xD;
      auragain 、ProSeal LMA and other new SGAs.&#xD;
&#xD;
      In the perioperative period, investigators documented respiratory function data including&#xD;
      oropharyngeal leak pressure and peak airway pressure in these randomly selected SGA.&#xD;
      Oropharyngeal leak pressure was measured by closing the expiratory valve of the circle system&#xD;
      at fixed O2 flow 3L/min and noting the airway pressure at which the dial on a calibrated&#xD;
      aneroid manometer reached equilibrium.&#xD;
&#xD;
      investigators wanted to compared the respiratory function between&#xD;
      air-Q、i-gel、LMA-supreme、AMBU auragain、ProSeal LMA and other new SGAs during surgery and&#xD;
      postoperative care unit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak pressures</measure>
    <time_frame>10 minutes</time_frame>
    <description>oropharyngeal leak pressure units ( cmH2O )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. The participant's head and neck position 2. The number of attempts required for SGA insertion 3. Ease of gastric tube placement 4. The ventilation score</measure>
    <time_frame>180 minutes</time_frame>
    <description>The participant's head and neck position (neutral/extension/flexion/rotation)&#xD;
The number of attempts required for SGA insertion (1/2/3/tracheal intubation)&#xD;
Ease of gastric tube placement (success/failure/Leak)&#xD;
The ventilation score was scored from 0 to 3 based on three criteria:&#xD;
(1) No leakage with an airway pressure of &gt; 15 cm H2O (2) Bilateral chest excursions with a peak inspiratory pressure of &gt; 20 cm H2O (3) A Square Wave Capnography with each item scoring 0 or 1 point. Thus, if all three criteria were satisfied, the ventilation score was 3.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Oropharyngeal Leak Pressure</condition>
  <arm_group>
    <arm_group_label>SGA type 1</arm_group_label>
    <description>Observe the function of SGA type 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SGA type 2</arm_group_label>
    <description>Observe the function of SGA type 2</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All general anesthesia patients who use SGA.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. 20-80 years old.&#xD;
&#xD;
          2. ASA physical status I or II .&#xD;
&#xD;
          3. Without major organ dysfunction like heart, liver, brain, lung, kidney function&#xD;
             failure.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. BMI&gt; 35 kg/m2.&#xD;
&#xD;
          2. Risk of aspiration(NPO clear water&gt; 2 hours, solid foods &gt; 8 hours).&#xD;
&#xD;
          3. Difficult airway like head and neck tumor or airway tumor.&#xD;
&#xD;
          4. Limited mouth opening (&lt;2cm).&#xD;
&#xD;
          5. major organ dysfunction including heart, liver, brain, lung, kidney function failure.&#xD;
&#xD;
          6. Major surgery including open heart surgery, laparotomy general surgery, open chest&#xD;
             surgery.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Chih Min</last_name>
    <role>Principal Investigator</role>
    <affiliation>visiting staff</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liu Chih Min</last_name>
    <phone>02-23123456</phone>
    <phone_ext>62158, 52224</phone_ext>
    <email>liu.chihmin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Chih Min</last_name>
      <phone>02-23123456</phone>
      <phone_ext>62158, 52224</phone_ext>
      <email>liu.chihmin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>November 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>November 24, 2020</last_update_submitted>
  <last_update_submitted_qc>November 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Supraglottic airway (SGA) devices</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

